The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Dec. 06, 2018
Applicant:

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Judy Lieberman, Brookline, MA (US);

Erwei Song, Guangzhou, CN;

Fengyan Yu, Guangzhou, CN;

Xiaoqu Hu, Guangzhou, CN;

Assignee:
Attorney:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 31/7105 (2006.01); A61K 47/68 (2017.01); A61K 31/7088 (2006.01); C12N 15/113 (2010.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 31/7088 (2013.01); A61K 45/06 (2013.01); A61K 47/6807 (2017.08); C12N 15/113 (2013.01); C12N 2310/11 (2013.01); C12N 2310/111 (2013.01); C12N 2310/141 (2013.01);
Abstract

The present invention relates to methods to treat or prevent cancers in a subject, in particular the present invention relates to a method of treating and/or preventing cancer comprising targeting cancer stem cells by administering miRNAs which have reduced expression or are lacking in the cancer stem cells. in some embodiments, the miRNAs that are reduced or lacking in cancer stem cells are let-7 miRNAs. In alternative embodiments, the present invention relates to a method of treating and/or preventing cancer comprising targeting cancer stem cells by administering miRNAs which have increased expression levels in the cancer stem cells. Another aspect of the present invention relates to methods to enrich for a cancer stem cell population. Another aspect of the present invention relates to methods to identify miRNAs which contribute to the self-renewal capacity of cancer stem cells.


Find Patent Forward Citations

Loading…